Pyrrolidine	pyrrolidine	B_chemical	O
dithiocarbamate	dithiocarbamate	I_chemical	O
protects	protects	O	O
the	the	O	O
piriform	piriform	O	O
cortex	cortex	O	O
in	in	O	O
the	the	O	O
pilocarpine	pilocarpine	S_chemical	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
model	model	O	O
.	.	O	O

Pyrrolidine	pyrrolidine	B_chemical	O
dithiocarbamate	dithiocarbamate	I_chemical	O
(	(	O	O
PDTC	pdtc	S_chemical	O
)	)	O	O
has	has	O	O
a	a	O	O
dual	dual	O	O
mechanism	mechanism	O	O
of	of	O	O
action	action	O	O
as	as	O	O
an	an	O	O
antioxidant	antioxidant	O	O
and	and	O	O
an	an	O	O
inhibitor	inhibitor	O	O
of	of	O	O
the	the	O	O
transcription	transcription	O	O
factor	factor	O	O
kappa-beta	kappa-beta	O	O
.	.	O	O

Both	both	O	O
,	,	O	O
production	production	O	O
of	of	O	O
reactive	reactive	B_chemical	O
oxygen	oxygen	S_chemical	O
species	species	I_chemical	O
as	as	O	O
well	well	O	O
as	as	O	O
activation	activation	O	O
of	of	O	O
NF-kappaB	nf-kappab	O	O
have	have	O	O
been	been	O	O
implicated	implicated	O	O
in	in	O	O
severe	severe	O	O
neuronal	neuronal	O	B_disease
damage	damage	O	I_disease
in	in	O	O
different	different	O	O
sub-regions	sub-regions	O	O
of	of	O	O
the	the	O	O
hippocampus	hippocampus	O	O
as	as	O	O
well	well	O	O
as	as	O	O
in	in	O	O
the	the	O	O
surrounding	surrounding	O	O
cortices	cortices	O	O
.	.	O	O

The	the	O	O
effect	effect	O	O
of	of	O	O
PDTC	pdtc	S_chemical	O
on	on	O	O
status	status	O	O
epilepticus-associated	epilepticus-associated	O	O
cell	cell	O	O
loss	loss	O	O
in	in	O	O
the	the	O	O
hippocampus	hippocampus	O	O
and	and	O	O
piriform	piriform	O	O
cortex	cortex	O	O
was	was	O	O
evaluated	evaluated	O	O
in	in	O	O
the	the	O	O
rat	rat	O	O
fractionated	fractionated	O	O
pilocarpine	pilocarpine	S_chemical	O
model	model	O	O
.	.	O	O

Treatment	treatment	O	O
with	with	O	O
150	150	O	O
mg/kg	mg/kg	O	O
PDTC	pdtc	S_chemical	O
before	before	O	O
and	and	O	O
following	following	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
significantly	significantly	O	O
increased	increased	O	O
the	the	O	O
mortality	mortality	O	O
rate	rate	O	O
to	to	O	O
100	100	O	O
%	%	O	O
.	.	O	O

Administration	administration	O	O
of	of	O	O
50	50	O	O
mg/kg	mg/kg	O	O
PDTC	pdtc	S_chemical	O
(	(	O	O
low-dose	low-dose	O	O
)	)	O	O
did	did	O	O
not	not	O	O
exert	exert	O	O
major	major	O	O
effects	effects	O	O
on	on	O	O
the	the	O	O
development	development	O	O
of	of	O	O
a	a	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
or	or	O	O
the	the	O	O
mortality	mortality	O	O
rate	rate	O	O
.	.	O	O

In	in	O	O
vehicle-treated	vehicle-treated	O	O
rats	rats	O	O
,	,	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
caused	caused	O	O
pronounced	pronounced	O	O
neuronal	neuronal	O	B_disease
damage	damage	O	I_disease
in	in	O	O
the	the	O	O
piriform	piriform	O	O
cortex	cortex	O	O
comprising	comprising	O	O
both	both	O	O
pyramidal	pyramidal	O	O
cells	cells	O	O
and	and	O	O
interneurons	interneurons	O	O
.	.	O	O

Low-dose	low-dose	O	O
PDTC	pdtc	S_chemical	O
treatment	treatment	O	O
almost	almost	O	O
completely	completely	O	O
protected	protected	O	O
from	from	O	O
lesions	lesions	O	O
in	in	O	O
the	the	O	O
piriform	piriform	O	O
cortex	cortex	O	O
.	.	O	O

A	a	O	O
significant	significant	O	O
decrease	decrease	O	O
in	in	O	O
neuronal	neuronal	O	O
density	density	O	O
of	of	O	O
the	the	O	O
hippocampal	hippocampal	O	S_disease
hilar	hilar	O	O
formation	formation	O	O
was	was	O	O
identified	identified	O	O
in	in	O	O
vehicle-	vehicle-	O	O
and	and	O	O
PDTC-treated	pdtc-treated	O	O
rats	rats	O	O
following	following	O	O
status	status	O	B_disease
epilepticus	epilepticus	O	I_disease
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
the	the	O	O
NF-kappaB	nf-kappab	O	O
inhibitor	inhibitor	O	O
and	and	O	O
antioxidant	antioxidant	O	O
PDTC	pdtc	S_chemical	O
protected	protected	O	O
the	the	O	O
piriform	piriform	O	O
cortex	cortex	O	O
,	,	O	O
whereas	whereas	O	O
it	it	O	O
did	did	O	O
not	not	O	O
affect	affect	O	O
hilar	hilar	O	O
neuronal	neuronal	O	B_disease
loss	loss	O	I_disease
.	.	O	O

These	these	O	O
data	data	O	O
might	might	O	O
indicate	indicate	O	O
that	that	O	O
the	the	O	O
generation	generation	O	O
of	of	O	O
reactive	reactive	B_chemical	O
oxygen	oxygen	S_chemical	O
species	species	I_chemical	O
and	and	O	O
activation	activation	O	O
of	of	O	O
NF-kappaB	nf-kappab	O	O
plays	plays	O	O
a	a	O	O
more	more	O	O
central	central	O	O
role	role	O	O
in	in	O	O
seizure-associated	seizure-associated	O	O
neuronal	neuronal	O	B_disease
damage	damage	O	I_disease
in	in	O	O
the	the	O	O
temporal	temporal	O	O
cortex	cortex	O	O
as	as	O	O
compared	compared	O	O
to	to	O	O
the	the	O	O
hippocampal	hippocampal	O	S_disease
hilus	hilus	O	O
.	.	O	O

However	however	O	O
,	,	O	O
future	future	O	O
investigations	investigations	O	O
are	are	O	O
necessary	necessary	O	O
to	to	O	O
exactly	exactly	O	O
analyze	analyze	O	O
the	the	O	O
biochemical	biochemical	O	O
mechanisms	mechanisms	O	O
by	by	O	O
which	which	O	O
PDTC	pdtc	S_chemical	O
exerted	exerted	O	O
its	its	O	O
beneficial	beneficial	O	O
effects	effects	O	O
in	in	O	O
the	the	O	O
piriform	piriform	O	O
cortex	cortex	O	O
.	.	O	O

